BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28189826)

  • 1. Targeted lipidomics reveals activation of resolution pathways in knee osteoarthritis in humans.
    Jónasdóttir HS; Brouwers H; Kwekkeboom JC; van der Linden HMJ; Huizinga T; Kloppenburg M; Toes REM; Giera M; Ioan-Facsinay A
    Osteoarthritis Cartilage; 2017 Jul; 25(7):1150-1160. PubMed ID: 28189826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct fatty acid signatures in infrapatellar fat pad and synovial fluid of patients with osteoarthritis versus rheumatoid arthritis.
    Mustonen AM; Käkelä R; Lehenkari P; Huhtakangas J; Turunen S; Joukainen A; Kääriäinen T; Paakkonen T; Kröger H; Nieminen P
    Arthritis Res Ther; 2019 May; 21(1):124. PubMed ID: 31118103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An explorative study comparing levels of soluble mediators in control and osteoarthritic synovial fluid.
    Beekhuizen M; Gierman LM; van Spil WE; Van Osch GJ; Huizinga TW; Saris DB; Creemers LB; Zuurmond AM
    Osteoarthritis Cartilage; 2013 Jul; 21(7):918-22. PubMed ID: 23598178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A lipidomic study of phospholipid classes and species in human synovial fluid.
    Kosinska MK; Liebisch G; Lochnit G; Wilhelm J; Klein H; Kaesser U; Lasczkowski G; Rickert M; Schmitz G; Steinmeyer J
    Arthritis Rheum; 2013 Sep; 65(9):2323-33. PubMed ID: 23784884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis?
    Pay S; Musabak U; Simsek I; Erdem H; Pekel A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S21-6. PubMed ID: 17949547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis.
    Barreto G; Soininen A; Ylinen P; Sandelin J; Konttinen YT; Nordström DC; Eklund KK
    Arthritis Res Ther; 2015 Dec; 17():379. PubMed ID: 26703441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from rheumatoid arthritis patients.
    Santos Savio A; Machado Diaz AC; Chico Capote A; Miranda Navarro J; Rodríguez Alvarez Y; Bringas Pérez R; Estévez del Toro M; Guillen Nieto GE
    BMC Musculoskelet Disord; 2015 Mar; 16():51. PubMed ID: 25879761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid mediators of inflammation in rheumatoid arthritis and osteoarthritis.
    Brouwers H; von Hegedus J; Toes R; Kloppenburg M; Ioan-Facsinay A
    Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):741-55. PubMed ID: 27107510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Tryptophan-related Metabolomic Profile in Rheumatoid Arthritis Synovial Fluid.
    Kang KY; Lee SH; Jung SM; Park SH; Jung BH; Ju JH
    J Rheumatol; 2015 Nov; 42(11):2003-11. PubMed ID: 26329338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial Fluid Fatty Acid Profiles Differ between Osteoarthritis and Healthy Patients.
    Van de Vyver A; Clockaerts S; van de Lest CHA; Wei W; Verhaar J; Van Osch GJVM; Bastiaansen-Jenniskens YM
    Cartilage; 2020 Oct; 11(4):473-478. PubMed ID: 30203669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of inflammation and resolution pathways of lipid mediators in synovial fluid from patients with severe rheumatoid arthritis compared with severe osteoarthritis.
    Sano Y; Toyoshima S; Miki Y; Taketomi Y; Ito M; Lee H; Saito S; Murakami M; Okayama Y
    Asia Pac Allergy; 2020 Apr; 10(2):e21. PubMed ID: 32411586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specialised pro-resolving mediators of inflammation in inflammatory arthritis.
    Barden AE; Moghaddami M; Mas E; Phillips M; Cleland LG; Mori TA
    Prostaglandins Leukot Essent Fatty Acids; 2016 Apr; 107():24-9. PubMed ID: 27033423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial proliferation differentially affects hypoxia in the joint cavities of rheumatoid arthritis and osteoarthritis patients.
    Lee YA; Kim JY; Hong SJ; Lee SH; Yoo MC; Kim KS; Yang HI
    Clin Rheumatol; 2007 Dec; 26(12):2023-2029. PubMed ID: 17393234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased n-6 Polyunsaturated Fatty Acids Indicate Pro- and Anti-Inflammatory Lipid Modifications in Synovial Membranes with Rheumatoid Arthritis.
    Mustonen AM; Tollis S; Käkelä R; Sihvo SP; Palosaari S; Pohjanen VM; Yli-Hallila A; Lehenkari P; Nieminen P
    Inflammation; 2023 Aug; 46(4):1396-1413. PubMed ID: 37140681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a distinct lipidomic profile in the osteoarthritic synovial membrane by mass spectrometry imaging.
    Rocha B; Cillero-Pastor B; Ruiz-Romero C; Paine MRL; Cañete JD; Heeren RMA; Blanco FJ
    Osteoarthritis Cartilage; 2021 May; 29(5):750-761. PubMed ID: 33582239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.
    Hashimoto A; Hayashi I; Murakami Y; Sato Y; Kitasato H; Matsushita R; Iizuka N; Urabe K; Itoman M; Hirohata S; Endo H
    J Rheumatol; 2007 Nov; 34(11):2144-53. PubMed ID: 17918787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis.
    Momohara S; Okamoto H; Iwamoto T; Mizumura T; Ikari K; Kawaguchi Y; Takeuchi M; Kamatani N; Tomatsu T
    J Rheumatol; 2007 Feb; 34(2):266-71. PubMed ID: 17304652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis.
    Chen JR; Takahashi M; Suzuki M; Kushida K; Miyamoto S; Inoue T
    J Rheumatol; 1998 Dec; 25(12):2440-4. PubMed ID: 9858442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular activation products in osteoarthritis synovial fluid.
    Renoux M; Hilliquin P; Galoppin L; Florentin J; Menkes CJ
    Int J Clin Pharmacol Res; 1995; 15(4):135-8. PubMed ID: 8871262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.